<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03827499</url>
  </required_header>
  <id_info>
    <org_study_id>2131/2018</org_study_id>
    <nct_id>NCT03827499</nct_id>
  </id_info>
  <brief_title>HMB Supplementation in Addition to Multicomponent Exercise in Old Adults</brief_title>
  <acronym>HEAL</acronym>
  <official_title>Effects of β-hydroxy-β-methylbutyrate (HMB) Supplementation in Addition to Multicomponent Exercise in Old Adults Living in Nursing Homes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Murcia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evidence supports the fact that multicomponent exercise and β-hydroxy-β-methylbutyrate (HMB)&#xD;
      supplementation are, separately, effective in improving old adult's health and palliate&#xD;
      functional metabolic diseases in the elderly. However, the true effect of HMB supplementation&#xD;
      combined with a tailored exercise program in frail old adults is still unknown. Thus, the aim&#xD;
      of the HEAL study is to assess the effects of the combination of a daily multicomponent&#xD;
      exercise and resistance training intervention in addition to HMB supplementation on old&#xD;
      adults' health.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evidence supports the fact that multicomponent exercise and β-hydroxy-β-methylbutyrate (HMB)&#xD;
      supplementation are, separately, effective in improving old adult's health and palliate&#xD;
      functional metabolic diseases in the elderly. However, the true effect of HMB supplementation&#xD;
      combined with a tailored exercise program in frail old adults is still unknown.&#xD;
&#xD;
      Thus, the aim of the HEAL study is to assess the effects of the combination of a daily&#xD;
      multicomponent exercise and resistance training intervention in addition to HMB&#xD;
      supplementation on old adults' health.&#xD;
&#xD;
      The findings of the HEAL study will help professionals from public health systems to identify&#xD;
      cost-effectiveness and innovative actions to improve older people's health and quality of&#xD;
      life, and endorse exercise practice in older adults living in nursing homes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 30, 2019</start_date>
  <completion_date type="Anticipated">January 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in physical functional performance based on the Short Physical Performance Battery (SPPB) score</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Summary scores range from 0-12 and higher scores denote higher physical performance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Handgrip strength (kg)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Using a dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lower-body strength (kg)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Seated leg press one-repetition maximun test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in upper-body strength (kg)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Vertical bench press one-repetition maximun test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lower-body strength power output (m/s)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Seated leg press load-velocity profile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in upper-body strength power output (m/s)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Vertical bench press load-velocity profile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in frailty (score)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Frailty phenotype determination using Fried's criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lean body mass (kg)</measure>
    <time_frame>Baseline to Week 25</time_frame>
    <description>Change in lean body mass using dual energy x-ray absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lipid profile</measure>
    <time_frame>Baseline to Week 25</time_frame>
    <description>Plasma total, high-density lipoprotein and low-density lipoprotein cholesterol and triglycerides (all in mg/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in glycaemic profile</measure>
    <time_frame>Baseline to Week 25</time_frame>
    <description>Plasma glucose, insulin and glycosylated haemoglobin (all in mg/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Thyroid-Stimulating Hormone (mIU/L)</measure>
    <time_frame>Baseline to Week 25</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Disability (Lawton index scores)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Disability in instrumental activities of daily living.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Disability (Barthel index scores)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Disability in basic activities of daily living</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Comorbidity (score)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>When a participant presents two or more geriatric syndromes from a list of selected geriatric syndromes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cognitive function (score)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Using the Mini-Mental State Examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in depression (score)</measure>
    <time_frame>Baseline to 25 Weeks</time_frame>
    <description>Using the 15-item Yesavage geriatric depression</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Aging</condition>
  <condition>Frail Elderly Syndrome</condition>
  <condition>Physical Activity</condition>
  <arm_group>
    <arm_group_label>Ex-HMB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HMB dietary supplementation and Multicomponent physical exercise program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NoEx-HMB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HMB Dietary supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ex-Plac</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Multicomponent physical exercise program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB dietary supplementation</intervention_name>
    <description>Intervention groups including HMB supplementation (Ex-HMB and NoEx-HMB) will receive a 3 g daily dose of free acid HMB in powder form dissolved freely into 250 mL of water during a 24-week intervention</description>
    <arm_group_label>Ex-HMB</arm_group_label>
    <arm_group_label>NoEx-HMB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multicomponent physical exercise program</intervention_name>
    <description>Intervention groups including exercise (Ex-HMB and Ex-Plac) will complete an individualized multicomponent training program, five days a week during 24 weeks.</description>
    <arm_group_label>Ex-HMB</arm_group_label>
    <arm_group_label>Ex-Plac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women aged ≥70 years living in a nursing home&#xD;
&#xD;
          -  Be able to follow an active physical rehabilitation program&#xD;
&#xD;
          -  Be able to read and wright&#xD;
&#xD;
          -  Voluntary participation&#xD;
&#xD;
          -  Capable and willing to provide an informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute heart attack (recent 3-6 months) or unstable angina&#xD;
&#xD;
          -  Uncontrolled atrial or ventricular arrhythmias&#xD;
&#xD;
          -  Aortic dissecting aneurysm&#xD;
&#xD;
          -  Severe aortic stenosis&#xD;
&#xD;
          -  Acute endocarditis / pericarditis&#xD;
&#xD;
          -  Uncontrolled high blood pressure (&gt;180/100 mmHg)&#xD;
&#xD;
          -  Acute thromboembolism&#xD;
&#xD;
          -  Acute or severe heart failure&#xD;
&#xD;
          -  Acute or severe respiratory failure&#xD;
&#xD;
          -  Uncontrolled postural hypotension&#xD;
&#xD;
          -  Uncontrolled acute decompensated diabetes mellitus or low blood sugar&#xD;
&#xD;
          -  A recent fracture in the last month.&#xD;
&#xD;
          -  Coincident participation in any intervention trial&#xD;
&#xD;
          -  HMB contraindication, intolerance, or allergy&#xD;
&#xD;
          -  Community-dwelling people&#xD;
&#xD;
          -  Have regularly performed exercise (&gt;20 minutes &gt;3 days/week) in the last 3 months&#xD;
&#xD;
          -  Malignant diseases (exceptions: basal or squamous-cell skin carcinoma or carcinoma in&#xD;
             situ of the uterine cervix)&#xD;
&#xD;
          -  Revascularization within 1 year&#xD;
&#xD;
          -  Severe loss of vision, hearing, or communicative ability&#xD;
&#xD;
          -  Conditions preventing cooperation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Sport Sciences</name>
      <address>
        <city>Murcia</city>
        <state>San Javier</state>
        <zip>30720</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 30, 2019</study_first_submitted>
  <study_first_submitted_qc>January 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2019</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Murcia</investigator_affiliation>
    <investigator_full_name>Javier Courel Ibáñez</investigator_full_name>
    <investigator_title>Ph.D</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

